New Jersey A970 allocates $2.5 million to DOBI for reimbursing joint insurance funds for COVID-19 surveillance testing costs.
New Jersey A970 appropriates $2.5 million from the General Fund to the Department of Banking and Insurance (DOBI). This funding is intended to reimburse joint insurance funds for covering COVID-19 surveillance testing costs for covered workers from August 6, 2021, to August 15, 2022. Despite federal guidelines not requiring joint insurance funds to cover these tests, some funds chose to do so.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.